AZD8542   Click here for help

GtoPdb Ligand ID: 7716

Synonyms: AZD 8542 | AZD-8542
Compound class: Synthetic organic
Comment: AZD8542 was developed as an antagonist of Smoothened (SMO), with potential as an oncology therapeutic [2]. This compound is now included in AstaZeneca's Open Innovation Pharmacology Toolbox.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 69.04
Molecular weight 412.19
XLogP 4.63
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1cnc(c1)c1cc(NC(=O)c2ccc(cc2)OCc2ccccn2)c(cc1C)C
Isomeric SMILES Cn1cnc(c1)c1cc(NC(=O)c2ccc(cc2)OCc2ccccn2)c(cc1C)C
InChI InChI=1S/C25H24N4O2/c1-17-12-18(2)23(13-22(17)24-14-29(3)16-27-24)28-25(30)19-7-9-21(10-8-19)31-15-20-6-4-5-11-26-20/h4-14,16H,15H2,1-3H3,(H,28,30)
InChI Key SMQVBAGSZVHCJP-UHFFFAOYSA-N
References
1. AstraZeneca. 
AZD8542.
Accessed on 12/09/2014. Modified on 12/09/2014. astrazeneca.com, http://openinnovation.astrazeneca.com/what-we-offer/compound/azd8542/
2. Hwang RF, Moore TT, Hattersley MM, Scarpitti M, Yang B, Devereaux E, Ramachandran V, Arumugam T, Ji B, Logsdon CD et al.. (2012)
Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer.
Mol Cancer Res, 10 (9): 1147-57. [PMID:22859707]